Skip to main content

Advertisement

SpringerLink
Log in

Hypertension

Testing for pre-eclampsia: paving the way to early diagnosis

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

A new study reports that a single blood test can be used to rule out the development of pre-eclampsia in women in whom the syndrome is suspected. Early interventions for pre-eclampsia are not yet available, but this finding is likely to change the approach to diagnosis of hypertensive disorders in pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Role of sFlt1 and PlGF in the development of pre-eclampsia.

References

  1. Redman, C. W. & Sargent, I. L. Latest advances in understanding preeclampsia. Science 308, 1592–1594 (2005).

    Article  CAS  Google Scholar 

  2. Zeisler, H. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374, 13–22 (2016).

    Article  CAS  Google Scholar 

  3. Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129–1136 (2008).

    Article  CAS  Google Scholar 

  4. Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707–716 (2003).

    Article  CAS  Google Scholar 

  5. Lu, F. et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J. Obstet. Gynecol. 196, 396.e1–396.e7; discussion 396.e7 (2007).

    Article  Google Scholar 

  6. Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672–683 (2004).

    Article  CAS  Google Scholar 

  7. McElrath, T. F. et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J. Obstet. Gynecol. 207, 407.e1–407.e7 (2012).

    Article  CAS  Google Scholar 

  8. Zhang, J., Klebanoff, M. A. & Roberts, J. M. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet. Gynecol. 97, 261–267 (2001).

    CAS  PubMed  Google Scholar 

  9. Thadhani, R. et al. Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2015020157 (2015).

  10. Thadhani, R. et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940–950 (2011).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

T.B. is supported by the German Research Foundation (BE2212 and SFB829, SFB832, SFB635). He apologizes to those whose work could not be cited owing to space limitations.

Author information

Authors and Affiliations

  1. Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Kerpener Street 62, Cologne, 50937, Germany

    Thomas Benzing

Authors
  1. Thomas Benzing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Benzing.

Ethics declarations

Competing interests

T.B. has received speaker honoraria from Hexal, Novartis, Kaneka and Otsuka.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benzing, T. Testing for pre-eclampsia: paving the way to early diagnosis. Nat Rev Nephrol 12, 200–202 (2016). https://doi.org/10.1038/nrneph.2016.21

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2016.21

  • Springer Nature Limited

Search

Navigation